JP2023503769A5 - - Google Patents
Info
- Publication number
- JP2023503769A5 JP2023503769A5 JP2022515083A JP2022515083A JP2023503769A5 JP 2023503769 A5 JP2023503769 A5 JP 2023503769A5 JP 2022515083 A JP2022515083 A JP 2022515083A JP 2022515083 A JP2022515083 A JP 2022515083A JP 2023503769 A5 JP2023503769 A5 JP 2023503769A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- cancer
- weight
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962900557P | 2019-09-15 | 2019-09-15 | |
| PCT/IB2020/000745 WO2021048626A1 (en) | 2019-09-15 | 2020-09-14 | Compositions for the treatment of solid tumors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023503769A JP2023503769A (ja) | 2023-02-01 |
| JP2023503769A5 true JP2023503769A5 (cg-RX-API-DMAC10.html) | 2023-09-04 |
| JP7822308B2 JP7822308B2 (ja) | 2026-03-02 |
Family
ID=74866186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515083A Active JP7822308B2 (ja) | 2019-09-15 | 2020-09-14 | 固形腫瘍の処置のための組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220323411A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4031130A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7822308B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN115066241A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2020347539B2 (cg-RX-API-DMAC10.html) |
| IL (1) | IL291351B1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021048626A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016203468A1 (en) | 2015-06-15 | 2016-12-22 | Raziel Therapeutics Ltd. | Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof |
| WO2022234337A2 (en) * | 2021-05-06 | 2022-11-10 | Raziel Therapeutics Ltd. | Crystalline carbazole derivative |
| WO2024100533A1 (en) * | 2022-11-07 | 2024-05-16 | Raziel Therapeutics Ltd. | Crystalline carbazole derivative and methods of making thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0311406D0 (en) * | 2003-05-17 | 2003-06-25 | Queen Mary & Westfield College | Substituted phosphonate fluorescent sensors,and use thereof |
| UA107652C2 (en) * | 2008-10-06 | 2015-02-10 | Incuron Llc | Carbazole compounds and therapeutic uses of the compounds |
| WO2013072915A1 (en) * | 2011-11-15 | 2013-05-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Tricyclic compounds, compositions comprising them and uses thereof |
| WO2016203468A1 (en) * | 2015-06-15 | 2016-12-22 | Raziel Therapeutics Ltd. | Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof |
| AU2021213469B2 (en) * | 2020-01-28 | 2026-06-04 | Raziel Therapeutics Ltd. | Compositions for the treatment of angiolipoma |
-
2020
- 2020-09-14 EP EP20863979.9A patent/EP4031130A4/en active Pending
- 2020-09-14 CN CN202080078495.3A patent/CN115066241A/zh active Pending
- 2020-09-14 AU AU2020347539A patent/AU2020347539B2/en active Active
- 2020-09-14 JP JP2022515083A patent/JP7822308B2/ja active Active
- 2020-09-14 WO PCT/IB2020/000745 patent/WO2021048626A1/en not_active Ceased
- 2020-09-14 US US17/642,153 patent/US20220323411A1/en active Pending
- 2020-09-15 IL IL291351A patent/IL291351B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7232796B2 (ja) | 第viii因子両性イオンポリマーコンジュゲート | |
| AU2019356168B2 (en) | Imaging agents | |
| JP2025510074A5 (cg-RX-API-DMAC10.html) | ||
| JP6162112B2 (ja) | 制御された放出システム | |
| JP2021501754A5 (cg-RX-API-DMAC10.html) | ||
| JP2021522275A5 (cg-RX-API-DMAC10.html) | ||
| JP2022533069A5 (cg-RX-API-DMAC10.html) | ||
| BR112012014556B1 (pt) | Polímero multifuncional conjugado zwiteriônico | |
| AU2018355222B2 (en) | Imaging and radiotherapeutics agents targeting fibroblast-activation protein-α (FAP-α) | |
| JP2012528240A5 (cg-RX-API-DMAC10.html) | ||
| RU2014115847A (ru) | Пирролопиримидиновые соединения для лечения злокачественной опухоли | |
| JP2023510865A5 (cg-RX-API-DMAC10.html) | ||
| RU2017122824A (ru) | Пирролопиримидиновое соединение | |
| AR010743A1 (es) | Compuestos de pirazol, utiles como inhibidores de la liberacion de acidos grasos mediada por la fosfolipasa a2 secretora no pancreatica humana.procedimientos para preparar dichos compuestos y composiciones farmaceuticas formuladas con dichos compuestos | |
| RU2014154009A (ru) | Комбинация ингибитора 17-альфа-гидроксилазы (с17,20-лиазы) и специфического ингибитора pi-3k для лечения онкологического заболевания | |
| JP2023512206A5 (cg-RX-API-DMAC10.html) | ||
| JP2021517164A5 (cg-RX-API-DMAC10.html) | ||
| JP2024545787A5 (cg-RX-API-DMAC10.html) | ||
| JP2022554094A5 (cg-RX-API-DMAC10.html) | ||
| JP2022546110A5 (cg-RX-API-DMAC10.html) | ||
| CN108601952A (zh) | 雷公藤内酯的葡萄糖缀合物、类似物及其用途 | |
| JP2023512227A5 (cg-RX-API-DMAC10.html) | ||
| JP2025508331A5 (cg-RX-API-DMAC10.html) | ||
| JP2007505044A5 (cg-RX-API-DMAC10.html) | ||
| JP2022550174A5 (cg-RX-API-DMAC10.html) |